Mechanisms of action of newer antibiotics for Gram-positive pathogens.

@article{Hancock2005MechanismsOA,
  title={Mechanisms of action of newer antibiotics for Gram-positive pathogens.},
  author={Robert E W Hancock},
  journal={The Lancet. Infectious diseases},
  year={2005},
  volume={5 4},
  pages={
          209-18
        }
}
Certain Gram-positive bacteria, including meticillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and quinolone-resistant Streptococcus pneumoniae have achieved the status of "superbugs", in that there are few or no antibiotics available for therapy against these pathogens. Only a few classes of novel antibiotics have been introduced in the past 40 years, and all since 1999, including the streptogramin combination quinupristin/dalfopristin (Synercid), the oxazolidinone… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 87 REFERENCES

Linezolid : the first oxazolidinone antimicrobial

DM Livermore
  • Ann Intern Med
  • 2003

Mechanism of action of oritavancin and related glycopeptide antibiotics

D Jabés, G Candiani, +3 authors M Cavaleri
  • FEMS Microbiol Rev
  • 2003